EU shores up pandemic defences with 478m flu vaccine deal
The European Union has snapped up advanced manufacturing capacity for at least 478 million doses of pandemic flu vaccine, surging ahead in the race to prepare for a possible bird flu outbreak in humans.
According to data from the health analytics firm Airfinity, the EU now has signed agreements with seven manufacturers to reserve vaccines – including a new deal unveiled last week with CSL Seqirus for a further 27m doses.
Although governments including Canada and the UK have reserved more doses per person, the EU has the largest and most diverse supply chain for a possible influenza pandemic.
As reported in the Lancet last week, the recent emergence of highly pathogenic H5N1 avian influenza virus infections in dairy cows and humans in the US has 'raised alarms regarding the potential for a pandemic'.
'Over 995 dairy cow herds and at least 70 humans have been affected, including cases of severe disease and the first reported H5N1-related death in the U.S'.
This emerging threat has caused health authorities across the globe to quietly start planning for a possible spillover to humans, with a clear focus on vaccine supply.
The shots the EU now has on standby do not constitute a stockpile. Rather than amassing a store of ready-to-use vaccines which protect against known strains of bird flu, the bloc has bet big on reserving access to outbreak-specific shots.
These would be produced after a pandemic was declared and the exact strain of the virus was known – giving the best chance of the jabs being efficacious in humans.
Richard Bennett, lead analyst at Airfinity, said the EU was also hedging its bets by doing deals with seven different firms.
'This diversification reduces the risk of supply disruption if one manufacturer encounters production issues, and prevents monopolising capacity from any single supplier,' he said.
Other countries have also set about reserving access to as-yet-unmade vaccines. Germany has secured production capacity or 400 million doses, under a framework that would also distribute manufactured jabs to the wider European Union.
Vaccine resilience and flexibility
Meanwhile the UK and Canada have reserved 100m and 80m doses respectively. Although this equates to more shots per person than the EU has access to (1.5 per capita for Britain, two for Canada and one for the EU), the supply chains are less diverse. Canada is reliant on GSK, while the UK has a single deal with CSL Seqirus, according to Airfinity.
Unlike the other countries included in the analysis, the US does not have enough doses to cover its entire population. Mr Bennet said this is unsurprising, 'given previous [US] demand for pandemic vaccines'.
During the H1N1 'swine flu' outbreak in 2009, national vaccine coverage was just 27 per cent, though this jumped to 69.5 per cent during the coronavirus pandemic.
Still, the superpower has 250m doses of pandemic flu shots reserved with CSL Seqirus and Sanofi, plus a stockpile of 20m shots against known strains of bird flu already circulating.
'Most countries depend on a handful of manufacturers for pandemic flu vaccines. Seven companies produce over 85 per of global supply, leaving national stockpiles vulnerable to geopolitical tensions, production delays, or supply chain shocks,' the Airfinity analysis warned.
'The EU has reduced reliance on single suppliers by securing contracts with multiple manufacturers, creating a more resilient and flexible vaccine procurement strategy during emergencies.'
Production delays and vaccine nationalism
The coronavirus pandemic highlighted the threat of vaccine nationalism, production delays and export restrictions. India's export bans, for instance, stalled the rollout of shots from Covax, which sought to buy immunisations for developing countries.
The US also imposed limits on the export of vaccines and the critical equipment and materials needed to make them, while the EU threatened to block the export of AstraZeneca shots made for the UK government in the Netherlands.
Ray Longstaff, director for Pandemic and Outbreak Preparedness and Response at CSL Seqirus, said the company has designed its manufacturing network and contracts to ensure minimum disruption in the face of these sorts of threats.
'In our agreements, we have supplied safeguards and comprehensive information about how we will not only meet the timelines … but also the kind of preparedness measures that we put in place to protect supply chains,' he said. 'It's something that we take very seriously.'
CSL Seqirus Liverpool's refrigerated warehouse, where vaccines for flu – including H5N1 – are stored before shipment - Simon Townsley/The Telegraph
The company – which has manufacturing sites in the UK, US and Australia – is one of the world's largest producers of seasonal flu shots. It also has a bird flu vaccine programme, plus a separate initiative to create pandemic-specific vaccines. If the WHO declared a pandemic, all manufacturing would switch to solely respond to the given outbreak.
The pharmaceutical firm's latest deal reserves 27.5m pandemic flu doses for 17 participating EU member states, which would be manufactured at the CSL Seqirus site in Liverpool using an egg-based production method. The company now has deals to supply pandemic shots to more than 30 governments worldwide, including the UK.
Mr Longstaff said he could not discuss specifics of the contracts – which include reservation fees that are invested in 'maintaining readiness and preparedness' – and downplayed the ramifications of potential tensions between governments in a pandemic scenario.
He also stressed that the company would support lower income countries through the WHO's Pandemic Influenza Preparedness (PIP) framework. Agreed after the 2009 swine flu outbreak, this requires companies to donate 10 per cent of their pandemic influenza shots, in real time.
This principle has also been incorporated into the new WHO pandemic treaty, set to be approved at the World Health Assembly in Geneva later this month, in an attempt to ensure that wealthy countries are not the only ones who have access to medical countermeasures in the event of an outbreak.
Protect yourself and your family by learning more about Global Health Security
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
32 minutes ago
- Medscape
Novo's Ozempic Linked to Rare Cases Of Serious Eye Disorder, EU Regulator Says
(Reuters) -Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision loss, the European Medicines Agency's safety committee said on Friday. In the past, studies in type-2 diabetes patients have linked Ozempic to the condition called non-arteritic anterior ischemic optic neuropathy (NAION). But this is the first time a regulator has confirmed the side effect. The condition may affect up to 1 in 10,000 people taking semaglutide, the active ingredient in Wegovy and Ozempic as well as in Novo's other diabetes drug Rybelsus, for at least one year, the regulator said. NAION is the second-most common cause of blindness due to optic nerve damage, after glaucoma. "This has been reported as a potential risk for some time, so I think the clinical community is relatively aware of it. I don't see this as making any major difference to prescribing patterns," said Barclays analyst Emily Field. U.S.-listed shares of the Danish drugmaker were up nearly 2.5% in early trading. The EMA, which started its review in December, has asked Novo to add NAION as a side effect of very rare frequency in the product information accompanying drugs that contain semaglutide. Novo said it would work with the EMA to update the labels, adding clinical trials and after-market studies did not suggest a reasonable possibility that the drugs caused the condition. The "benefit-risk profile of semaglutide remains favorable," the company said in a statement. Novo has recently faced investor concerns that it is losing its first-mover advantage in the highly competitive obesity treatment market, leading the company to oust CEO Lars Fruergaard Jorgensen in May. Wegovy and Eli Lilly's Zepbound currently dominate the weight-loss drug market, potentially worth about $150 billion by the next decade. The EMA said several large studies in type-2 diabetes patients have suggested that use of Novo's drugs could raise the risk of developing NAION by twofold. A study of nearly 350,000 diabetes patients published in March showed that the risk of developing NAION more than doubled after two years of treatment with Ozempic, compared to patients taking medicines from other classes. The U.S. Department of Health and Human Services did not immediately respond to a Reuters request for comment on whether the Food and Drug Administration was conducting a probe into the side effect. (Reporting by Manas Mishra and Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
Yahoo
an hour ago
- Yahoo
EU Seeks Deeper G-7 Defense Ties to Offset Trump's Upheaval
(Bloomberg) -- The European Union is racing to strengthen defense ties with key Group of Seven allies as President Donald Trump pares back the US commitment to the continent's security. Next Stop: Rancho Cucamonga! ICE Moves to DNA-Test Families Targeted for Deportation with New Contract Where Public Transit Systems Are Bouncing Back Around the World US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents Warn Trump Said He Fired the National Portrait Gallery Director. She's Still There. The EU is aiming to conclude a defense and security partnership with Canada this month that will pave the way for Canadian companies to participate in a new defense fund meant to jump start a transformation of the bloc's industry, according to people familiar with the matter. The EU will also hold a summit with Japan in July when they'll seek to beef up a security agreement, said the people, who spoke on the condition of anonymity. The EU is diversifying its relationships as Trump has upended the European security order that's maintained peace on the continent for more than 70 years. During his first term, Trump threatened to leave NATO and last year he said he'd let Russia do 'whatever the hell they want' to allies not spending enough on defense. The US president's abrupt pullback has led to the EU mobilizing hundreds of billions of euros to ramp up its defense spending. The defense agreement with Canada is expected to be one of the key deliverables of a summit both allies will hold in Brussels on June 23, intended to show the bloc's alignment with like-minded nations in this turbulent period, the people said. The pact will follow the blueprint set by a similar defense accord reached with the United Kingdom in May. As with the UK, such an agreement would be a stepping stone toward allowing Canadian firms to participate in the bloc's new €150 billion ($171 billion) loan-based fund to develop the EU's defense industry. Although Canada wants a strong signal from the summit with regards to its industry's full access to the new EU instrument, a security and defense pact only grants partial access to the bloc's fund, and full access would require another bilateral deal. Canada, a long-standing EU partner in security matters, is also participating in two other initiatives aimed at strengthening defense cooperation among willing member states, covering military mobility and the development of a network of logistics hubs in Europe. Similar to other defense partnerships signed by the bloc, the draft text, still under discussion, will also note shared interests, common threats, expected joint dialogues and several areas of cooperation, the people said. The bilateral summit between the EU and Japan will aim to strengthen a defense pact signed late last year by tapping into closer naval cooperation, among other measures. A spokesperson for the European Council chief, Antonio Costa, said the twin summits aim to 'deepen even more the already very close relationship that we have with these two key partners.' The EU has previously signed security and defense partnerships on issues like missions, training or industrial cooperation, with countries such as Albania, Japan, Moldova, North Macedonia, Norway and South Korea. In addition to defense, the EU is also looking to strengthen ties with both G-7 allies around a competitiveness alliance, although in the case of Japan the work is more advanced. Such new framework would serve to group existing bilateral initiatives in the field of economic security, supply chain resilience and competitiveness, although discussions continued between negotiators to determine the content and the format, the people said. --With assistance from Andrea Palasciano. Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again YouTube Is Swallowing TV Whole, and It's Coming for the Sitcom The SEC Pinned Its Hack on a Few Hapless Day Traders. The Full Story Is Far More Troubling Is Elon Musk's Political Capital Spent? Trump Considers Deporting Migrants to Rwanda After the UK Decides Not To ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business of Fashion
an hour ago
- Business of Fashion
Under Pressure: Can Fashion's Sustainability Efforts Survive?
Every year, fashion's climate campaigners descend on Copenhagen for the Global Fashion Summit, the industry's highest-profile sustainability gathering. The event, which is typically dominated by large brands offering up a relentlessly optimistic prognosis on the industry's climate efforts, was unusually downbeat this year. Many of fashion's biggest companies were noticeably absent — a function of squeezed travel budgets and fear (few executives appeared willing to weigh in on an increasingly politically charged topic where there is little positive to say). To be sure, advocates for a greener, kinder fashion industry have quietly acknowledged that the movement was struggling for a while. But they held out hope that moves to toughen up regulation would keep forcing things forward. This year, that has all but evaporated. A rightward swing in Europe has prompted a regulatory rollback in the name of competitiveness. Brussels is pushing to cut red tape and simplify pioneering environmental reporting and due diligence requirements in a move critics argue undermines the legislation. 'Europe has failed,' Danish brand Bestseller's stakeholder engagement and human rights manager, Claus Teilmann Petersen, said during a panel discussion teeing up the summit. 'I see this battle as being… kind of lost.' Then there is the active threat posed by the Trump administration, which has pulled the US out of the Paris Climate agreement, slashed funding from programmes focused on labour rights and climate action and launched a chaotic trade war that has plunged much of the industry into survival mode. Instead of looking for progress, many in the space are just trying to figure out what can be saved. 'There's this sort of paralysis that's happening right now,' the American Apparel and Footwear Association's senior director for sustainability Chelsea Murtha told the summit. 'Everyone's trying to figure out what can we continue to hold onto.' What Next? On the sidelines, many insiders acknowledged the movement is running on fumes. Already some companies are making small sustainability sacrifices in the name of economising, opting to switch out pricier lower impact materials for cheaper, more conventional ones, I was told. Attendees said expected companies to largely stay the course with programmes already in place, but acknowledged the uncertainty was likely to slow future action. It's not clear where new momentum could come from. Until there's more clarity on tariffs, the industry is holding a collective breath. The EU is still pushing forward with regulations that would set more sustainable design and recycling requirements, but these have yet to be fully defined. Alongside the usual calls for more collective action and innovation, there was a greater focus on the importance of advocacy in favour of policies that could lend fresh support to fashion's climate efforts. 'We need to have courage,' said slow fashion pioneer Eileen Fisher. 'We have to do more and show up and collaborate more.' The real remaining wild card is climate change itself. This year is once again on track to be one of the warmest on record. Increasingly extreme weather is a threat to raw material supply chains, worker safety and retail traffic. So far, disruptions from floods, wildfires and searing heat have not led to significant disruptions for the industry. Still, with future costs of climate change expected to mount into the trillions of dollars in the future, fashion may come to regret complacency today. THE NEWS IN BRIEF FASHION, BUSINESS AND THE ECONOMY (Getty Images) Gucci owner Kering is in talks to sell its stake in a $1 billion Fifth Avenue property. The negotiations to sell the 115,00-square-foot property which Kering purchased last year to buyout group Ardian are part of the French luxury group's strategy to cut costs and sell stakes in prime real estate to shrink its debt, Reuters reported. Lululemon cut its annual profit forecast as demand slows amid looming tariffs. Despite new product offerings, the activewear company's sales momentum is lagging behind that of competitors like Alo Yoga and Vuori. Stock plummeted 12 percent in after-market trading on Thursday. Prada acquired a 10 percent stake in Italian leather group Rino Mastrotto. Under the deal, which comes as the Italian luxury group aims to shore up control over its production processes, Prada will give the Renaissance Partners-backed leather group a cash investment of undisclosed value and two tanneries. Cartier reported some customer data was stolen in a cyberattack. The Richemont-owned jeweller's client information, including email addresses, countries and names, was obtained by cybercriminals after its website was hacked. The incident is the latest in a wave of cyberattacks on retailers. Rent the Runway forecast double-digit subscriber growth in 2025. Shares rose 12 percent Thursday afternoon after the rental service announced it had ended its most recent quarter with a record number of active subscribers. Year-on-year revenue fell 7.2 percent to $70 million. De Beers drew interest from ex-CEOs as Anglo started its sale. Anglo American Plc plans to begin a formal sales process for De Beers, the final step in its restructuring plan. Former De Beers CEOs Gareth Penny and Bruce Cleaver, and Australian miner Michael O'Keeffe are reportedly each leading groups of potential buyers. A Skechers shareholder sued the company over details on the $9.4 billion 3G buyout. The shareholder alleged founder and controlling shareholder Robert Greenberg to have 'controlled the sales process to a single bidder and deprived the minority stockholders of any legitimate bidding process,' according to the legal complaint. Shein was hit with a complaint from an EU consumer group over 'dark patterns.' Pan-European consumer organisation BEUC filed a complaint with the European Commission on Thursday, citing 'aggressive commercial practices' like pop-ups, notifications and countdown timers that pressure people to make a purchase on Shein's app and website. Victoria's Secret said a cyber incident led to its temporary website shutdown. The intimates chain said it detected an information technology systems-related security incident, which caused it to shut down its website between May 26 and May 29. The incident did not impact its first-quarter financial results. Temu's daily US users have halved following the end of the 'de minimis' loophole. The site's daily US users plummeted 58 percent in May. Both Temu and Shein have suffered a severe drop in sales and customer growth rates since US President Trump announced sweeping trade tariffs and the end of low-value duty-free shipments from China. Sotheby's will auction an original Hermès bag that belonged to Jane Birkin. The black leather handbag, which was initially commissioned in 1984 for the late singer before being commercialised under her name, will be made available for sale in Paris on July 10. THE BUSINESS OF BEAUTY (Huda Beauty) Huda Kattan bought back Huda Beauty. Iraqi-American beauty influencer Kattan regained full ownership of her eponymous brand after buying back a minority stake that private equity firm TSG Consumer Partners had held since 2017. L'Oréal is reportedly poised to acquire Medik8. The Financial Times reported that the British skincare brand's current owner, private equity group Inflexion, and L'Oréal are close to finalising an agreement. Procter & Gamble will cut 7,000 jobs over two years. The manufacturing company announced it would cut about 6 percent of its global workforce, with plans to exit some categories and brands in individual markets. PEOPLE () Nike's CEO finished his C-suite makeover with a former McDonald's executive. McDonald's senior VP Michael Gonda will join the world's largest sportswear brand as chief communications officer in July, the latest leadership reshuffling under the turnaround strategy of CEO Elliott Hill, who rejoined Nike from retirement in October. Better Cotton appointed Nick Weatherill CEO. Weatherill, a former International Cocoa Initiative executive director, will succeed longtime CEO Alan McClay. The 20-year-old sustainable cotton initiative now certifies a fifth of the world's cotton production, but is amping up its oversight following criticism that its standards are too lenient. Kiko Milano named Drew Elliott its chief brand officer. Elliot, the former MAC Cosmetics global creative director, will assume the chief brand officer role on Sept. 1. The appointment comes as the Italian cosmetics company looks to expand its presence in the US market. Violet Grey named a former Bluemercury executive as group president. Tracy Kline will join the beauty retailer as group president on June 9, overseeing the company's team, supply chain, stores, merchandising and marketing. Longtime beauty editor Jane Larkworthy died at 62. Larkworthy, who served as the beauty director of W magazine and more recently as a columnist for New York Magazine's The Cut, is credited as the editor responsible for popularising Le Labo's Santal 33. She died on Wednesday after a battle with cancer. Compiled by Jessica Kwon.
